Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
F1000Research|May 12, 2017
Selective vulnerabilities and biomarkers in neurocognitive agingZachariah Reagh, Michael YassaExpert Review of Endocrinology & Metabolism|February 16, 2019
Prostate cancer and androgenic alopeciaMichael Yassa, Tarek Hijal, Philippe GiraudExpert Review of Endocrinology & Metabolism|August 1, 2018
Hypofractionation for prostate cancer: an updateDavid Tiberi, Peter Vavassis, David Nguyen, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the LiteratureRejane Franco, Jeffrey Q Cao, Michael Yassa, et al.Expert Review of Anticancer Therapy|August 1, 2012
Hypofractionated radiotherapy in prostate cancerPeter Vavassis, David H A Nguyen, Jean-Paul Bahary, et al.Journal of Neuro-Oncology|September 28, 2005
Intra-parenchymal mesenchymal chondrosarcoma of the cerebellum: case report and review of the literatureMichael Yassa, Jean-Paul Bahary, Pierre Bourguoin, et al.Technical Innovations & Patient Support in Radiation Oncology|February 26, 2020
Are radiation oncologists following guidelines? An audit of practice in patients with uncomplicated bone metastasesVanessa Di Lalla, Bernard Fortin, Catherine Pembroke, et al.International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancerMichael Yassa, Bernard Fortin, Marie-Andrée Fortin, et al.Practical Radiation Oncology|April 1, 2015
Partial kilovoltage cone beam computed tomography, complete kilovoltage cone beam computed tomography, and electronic portal images for breast radiation therapy: A dose-comparison studyHouda Bahig, Étienne Roussin, Michael Yassa, et al.Annals of Diagnostic Pathology|November 5, 2022
Tumor bed extending to margins in breast cancer specimens after neoadjuvant chemotherapy: Incidence and clinical significanceMarie-Hélène Ngo, Mai-Kim Gervais, Guy Leblanc, et al.Pageof 4